Evidence check: FADS1 in the context of allergy

FADS1 (fatty acid desaturase 1) encodes an enzyme that converts omega-3 and omega-6 fatty acids into long-chain polyunsaturated fatty acids, which are precursors for eicosanoids involved in inflammation and immune regulation. Some studies have linked FADS1 variants to allergic diseases such as asthma, hay fever, and atopic dermatitis, possibly through altered arachidonic acid and prostaglandin levels. However, the evidence is mixed: GWAS show moderate associations, but there are no RCTs demonstrating that personalized dietary advice based on FADS1 improves allergy outcomes. MyBody-X offers allergy and nutrition tests, but FADS1 is not specifically mentioned in the provided context. The predictive value of a single SNP for complex allergic conditions is limited. While increasing omega-3 intake may have general anti-inflammatory benefits, deriving specific recommendations from FADS1 alone is not evidence-based. Caution is warranted against overblown marketing claims. Evidence rating: mechanistic/unclear.